跳至主要内容
临床试验/CTRI/2024/08/072210
CTRI/2024/08/072210尚未招募不适用

Follow up study of the patients enrolled in a hospital based multi center registry for common medical retinal diseases

BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL3 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
2,000
试验地点
3
主要终点
1.To evaluate the progression of the disease after the visit

研究概览

简要总结

Our aim was to develop a multicentre registry in order to facilitate future RCTs in common medical retinal diseases amenable to treatment with biologics like anti VEGF. Such a registry will  facilitate  recruitment  by  matching  potential participants  interested  in  research  with approved clinical studies using study entry criteria taken from patient visiting OPDs after obtaining their informed consent. The follow up study will evaluate the progression of the disease  and  change of  visual acuity of the patients who were already enrolled in the registry entitled  â€œA hospital-based multicentre registry for common medical retinal diseases”

This is a hospital based multicenter registry which will be conducted without any intervention. The data of patients who were already in the registry entitled  â€œA hospital-based multicentre registry for common medical retinal diseases” will be collected.

Data collection includes details of  any new comorbid diseases ,  previous diagnosis as per baseline visit, current diagnosis as per latest visit, any procedure done after baseline  visit, ophthalmic assessment including  best corrected visual acuity (logmar) ,    intraocular pressure, OCT-central macular thickness  , OCT-central macular volume  and mydriatic fundus photographs.

The assessment of changes in continuous variable outcomes like BCVA, CMT, and CMV from baseline to follow-up involves the utilization of either Repeated Measures ANOVA or the Friedman Test.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Patients with these aforementioned stages of diabetic retinopathy,
  • Central and branch retinal vein occlusions
  • Age related macular degeneration or CNVM who are already enrolled in the registry entitled “A hospital-based multicentre registry for common medical retinal diseases”
  • Patients who were already enrolled in the registry entitled “A hospital-based multicentre registry for common medical retinal diseases.

排除标准

  • Patients who were not enrolled in the registry entitled “A hospital-based multicentre registry for common medical retinal diseases.

结局指标

主要结局

1.To evaluate the progression of the disease after the visit

时间窗: 6 Months

次要结局

  • 1. To evaluate the real world treatment of patients who were enrolled into the registry.(2. To evaluate the efficacy of treatment of patients through change in vision.)

研究者

申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Gopal S Pillai

Amrita Institute of Medical Sciences and Research Centre, Kochi Kerala

研究点 (3)

Loading locations...

相似试验